Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AgPlus Diagnostics Ltd.

Latest From Biotrack Inc.

Activx Biosciences Inc.

Activx Biosciences Inc. is positioning itself as a second-generation proteomics company with what it claims is the first high-throughput chemistry platform for activity-based proteomics. The company aims to convert the massive amounts of raw genomics data into targets for drug discovery by using chemical probes to directly measure protein activity.
BioPharmaceutical Strategy

Vascular Therapeutics Inc.

Vascular Therapeutics is developing drugs to treat clotting disorders at the molecular level.
See All

Company Information

  • Industry
  • Biotechnology
    • Nanotechnology, Chips, etc.
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Argento Diagnostics
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • AgPlus Diagnostics Ltd.
  • Senior Management
  • Keith Page, CEO
    Robert Porter, PhD, CSO
  • Contact Info
  • AgPlus Diagnostics Ltd.
    Phone: (0)1234 867 100
    Colworth Science Park
    The Exchange
    Sharnbrook, Bedfordshire, MK44 1LQ